← All patents

US10875912B2

EGFL6 specific monoclonal antibodies and methods of their use

University of Texas System

Abstract

Isolated or recombinant anti-EGFL6 monoclonal antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer.

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Ningyan Zhang
Priority date
February 05, 2016
Filing date
February 06, 2017
Grant date
December 29, 2020
Publication date
December 29, 2020
Language
en
Metadata fetched
August 29, 2026 00:27